Meld Valuation / Venture NAV Tracker
FundsCompaniesMethodology
meldvaluation.com ↗

Venture NAV Tracker / Private company

enGene, Inc.

Drug Discovery & Development
Headquarters—
Founded—
Last known round—
Reported valuation—

Cross-fund comparison

Equity & warrant marks

One latest disclosed mark per fund.

FundFair valueSecurity / basisImplied price / shareMark age vs roundMethodology / filing
HTGCHercules Capital, Inc.$151KMar 31, 2026 · source ↗warrantFair Value$2.09Mar 31, 2026 · source ↗—Mar 31, 2026 · source ↗10-Q 2026-03-31 ↗

Cross-fund comparison

Debt investments

One latest disclosed debt mark per fund.

FundSecurity type / basisPrincipalFair valueFV / principalRateMaturityMark age vs roundNon-accrual
HTGCHercules Capital, Inc.senior secured loanFair Value — Senior Secured$17.5MMar 31, 2026 · source ↗$18.3MMar 31, 2026 · source ↗104.5%Mar 31, 2026 · source ↗Prime + 2.25 %, Floor rate 9.25 %, Cap rate 10.25 %, 5.95 % Exit FeeMar 31, 2026 · source ↗Jan 1, 2030Mar 31, 2026 · source ↗—Mar 31, 2026 · source ↗NoMar 31, 2026 · source ↗

Historical marks

Reported fair value by fund

Each bar is a disclosed position-quarter.

$18.3MHTGCMar 31, 2026 · source ↗$151KHTGCMar 31, 2026 · source ↗
Figures are compiled from public filings.Read methodologyMELD Valuation